2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-N6-propyl-, (6S)-

The Pramipexole with CAS registry number of 104632-26-0 is also known as 2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-N6-propyl-, (6S)-. The IUPAC name is (6S)-6-N-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine. It belongs to classes of All Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals. In addition, the molecular formula is C₁₀H₁₇N₃S and the molecular weight is 211.33. And it should be stored in a cool and dry place.

Physical properties about Pramipexole are: (1)ACD/LogP: 1.42; (2)ACD/LogD (pH 5.5): -1.97; (3)ACD/LogD (pH 7.4): -0.53; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 1.6; (8)#H bond acceptors: 3; (9)#H bond donors: 3; (10)#Freely Rotating Bonds: 3; (11)Index of Refraction: 1.582; (12)Molar Refractivity: 60.3 cm³; (13)Molar Volume: 180.4 cm³; (14)Surface Tension: 53.1 dyne/cm; (15)Density: 1.17 g/cm³; (16)Flash Point: 182.4 °C; (17)Enthalpy of Vaporization: 62.58 kJ/mol; (18)Boiling Point: 378 °C at 760 mmHg; (19)Vapour Pressure: 6.49E-06 mmHg at 25 °C.

Preparation of Pramipexole: it is prepared by reaction of a cyclohexanone derivative by the following route.

Uses of Pramipexole: it is a non-ergoline dopamine agonist indicated for treating early-stage Parkinson's disease (PD) and restless legs syndrome (RLS). It has shown robust effects on pilot studies in a placebo-controlled proof of concept study in bipolar disorder. Moreover, it can be used to treat cluster headache, clinical depression and fibromyalgia.

You can still convert the following datas into molecular structure:
(1)SMILES: n1c2c(sc1N)C[C@@H](NCCC)CC2
(2)InChI: InChI=1/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m0/s1
(3)InChIKey: FASDKYOPVNHBLU-ZETCQYMHBT